Key result
Advances in molecular diagnostics, neuroimaging, and antiviral therapies are improving the recognition and management of pediatric central nervous system viral infections.
This review highlights advances in diagnostic technologies and therapies for pediatric central nervous system viral infections.
May guide refined diagnostics in pediatric CNS viral infections; leaves open prospective validation of therapeutic impact.
Viral infections of the pediatric central nervous system (CNS) encompass a broad spectrum of both perinatally and postnatally acquired diseases with potentially devastating effects on the developing brain. In children, viral infections have been associated with chronic encephalopathy, encephalitis, demyelinating disease, tumors, and epilepsy. Older diagnostic techniques of biopsy, viral culture, electron microscopy, gel-based polymerase chain reaction (PCR), and viral titer quantification are being replaced with more rapid, sensitive, and specific real-time and microarray-based PCR technologies. Advances in neuroimaging technologies have provided for earlier recognition of CNS injury without elucidation of specific viral etiology. Although the mainstay therapy of many pediatric neurovirologic diseases, aside from HIV, includes intravenous acyclovir, much work is being done to develop novel antiviral immunotherapies aimed at both treating and preventing pediatric CNS viral disease.
No takes yet. Share an insight, caveat, or question.
John R. Crawford (2010) conducted a review in Pediatric central nervous system viral infections. Diagnostic and therapeutic modalities was evaluated. Advances in molecular diagnostics, neuroimaging, and antiviral therapies are improving the recognition and management of pediatric central nervous system viral infections.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: